BIOMAT Database Logo BIOMAT Database Logo

[Fibrinolytic therapy in myocardial infarct]. 1967

G Steingass

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase

Related Publications

G Steingass
[Fibrinolytic therapy in acute myocardial infarct].
December 1973, Schweizerische medizinische Wochenschrift,
G Steingass
[Fibrinolytic therapy in acute myocardial infarct].
January 2003, Casopis lekaru ceskych,
G Steingass
[Anticoagulant and fibrinolytic therapy of myocardial infarct].
January 1973, Kardiologiia,
G Steingass
[Experiences with fibrinolytic therapy in acute myocardial infarct].
January 1972, Medicinski arhiv,
G Steingass
[Initial experiences with fibrinolytic therapy of acute myocardial infarct].
February 1963, Deutsches medizinisches Journal,
G Steingass
[Clinical aspects of the fibrinolytic therapy of myocardial infarct].
July 1967, Wiadomosci lekarskie (Warsaw, Poland : 1960),
G Steingass
[Experience with fibrinolytic therapy in acute myocardial infarct (Czechoslovak Socialist Republic)].
November 1979, Voenno-meditsinskii zhurnal,
G Steingass
[Clinical-experimental findings in the fibrinolytic therapy of fresh myocardial infarct].
January 1972, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
G Steingass
[Fibrinolytic treatment of acute myocardial infarct].
August 1986, Fortschritte der Medizin,
G Steingass
[Proceedings: Ischemic heart disease and plasma fibrinolytic activity. (4). Fibrinolytic enzyme therapy in acute myocardial infarct].
July 1975, Japanese circulation journal,
Copied contents to your clipboard!